{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:17:53Z","timestamp":1791152273461,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T00:00:00Z","timestamp":1414022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T00:00:00Z","timestamp":1414022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/gt.2014.94","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T10:18:21Z","timestamp":1414059501000},"page":"163-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Sustained inhibition of hepatitis B virus replication in vivo using RNAi-activating lentiviruses"],"prefix":"10.1038","volume":"22","author":[{"given":"D","family":"Ivacik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Arbuthnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,23]]},"reference":[{"key":"BFgt201494_CR1","unstructured":"WHO. Hepatitis B Virus Fact Sheet No. 204 (Revised 2014). WHO: Geneva, Switzerland, 2000."},{"key":"BFgt201494_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1046\/j.1440-1746.2000.02069.x","volume":"15","author":"P Arbuthnot","year":"2000","unstructured":"Arbuthnot P, Capovilla A, Kew M . Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK\/STAT pathways. J Gastroenterol Hepatol 2000; 15: 357\u2013368.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFgt201494_CR3","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1093\/jac\/dkr388","volume":"66","author":"J Fung","year":"2011","unstructured":"Fung J, Lai CL, Seto WK, Yuen MF . Nucleoside\/nucleotide analogues in the treatment of chronic hepatitis B. J Antimicrob Chemother 2011; 66: 2715\u20132725.","journal-title":"J Antimicrob Chemother"},{"key":"BFgt201494_CR4","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1056\/NEJM199712113372406","volume":"337","author":"WM Lee","year":"1997","unstructured":"Lee WM . Hepatitis B virus infection. N Engl J Med 1997; 337: 1733\u20131745.","journal-title":"N Engl J Med"},{"key":"BFgt201494_CR5","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/mt.2008.82","volume":"16","author":"A Ely","year":"2008","unstructured":"Ely A, Naidoo T, Mufamadi S, Crowther C, Arbuthnot P . Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo. Mol Ther 2008; 16: 1105\u20131112.","journal-title":"Mol Ther"},{"key":"BFgt201494_CR6","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1093\/nar\/gkp446","volume":"37","author":"A Ely","year":"2009","unstructured":"Ely A, Naidoo T, Arbuthnot P . Efficient silencing of gene expression with modular trimeric Pol II expression cassettes comprising microRNA shuttles. Nucleic Acids Res 2009; 37: e91.","journal-title":"Nucleic Acids Res"},{"key":"BFgt201494_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1073\/pnas.0409028102","volume":"102","author":"SL Uprichard","year":"2005","unstructured":"Uprichard SL, Boyd B, Althage A, Chisari FV . Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc Natl Acad Sci USA 2005; 102: 773\u2013778.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201494_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ymthe.2005.10.013","volume":"13","author":"S Carmona","year":"2006","unstructured":"Carmona S, Ely A, Crowther C, Moolla N, Salazar FH, Marion PL et al. Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs. Mol Ther 2006; 13: 411\u2013421.","journal-title":"Mol Ther"},{"key":"BFgt201494_CR9","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1089\/hum.2008.066","volume":"19","author":"C Crowther","year":"2008","unstructured":"Crowther C, Ely A, Hornby J, Mufamadi S, Salazar F, Marion P et al. Efficient inhibition of hepatitis B virus replication in vivo, using polyethylene glycol-modified adenovirus vectors. Hum Gene Ther 2008; 19: 1325\u20131331.","journal-title":"Hum Gene Ther"},{"key":"BFgt201494_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature04791","volume":"441","author":"D Grimm","year":"2006","unstructured":"Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR et al. Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways. Nature 2006; 441: 537\u2013541.","journal-title":"Nature"},{"key":"BFgt201494_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/mt.2008.245","volume":"17","author":"CC Chen","year":"2009","unstructured":"Chen CC, Sun CP, Ma HI, Fang CC, Wu PY, Xiao X et al. Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9. Mol Ther 2009; 17: 352\u2013359.","journal-title":"Mol Ther"},{"key":"BFgt201494_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.272.5259.263","volume":"272","author":"L Naldini","year":"1996","unstructured":"Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263\u2013267.","journal-title":"Science"},{"key":"BFgt201494_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/71673","volume":"24","author":"F Park","year":"2000","unstructured":"Park F, Ohashi K, Chiu W, Naldini L, Kay MA . Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat Genet 2000; 24: 49\u201352.","journal-title":"Nat Genet"},{"key":"BFgt201494_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/hep.21668","volume":"46","author":"Y Chen","year":"2007","unstructured":"Chen Y, Lin MC, Yao H, Wang H, Zhang AQ, Yu J et al. Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. Hepatology 2007; 46: 200\u2013208.","journal-title":"Hepatology"},{"key":"BFgt201494_CR15","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1002\/hep.22531","volume":"48","author":"BS Sun","year":"2008","unstructured":"Sun BS, Dong QZ, Ye QH, Sun HJ, Jia HL, Zhu XQ et al. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatology 2008; 48: 1834\u20131842.","journal-title":"Hepatology"},{"key":"BFgt201494_CR16","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/nbt1372","volume":"25","author":"BD Brown","year":"2007","unstructured":"Brown BD, Gentner B, Cantore A, Colleoni S, Amendola M, Zingale A et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 2007; 25: 1457\u20131467.","journal-title":"Nat Biotechnol"},{"key":"BFgt201494_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/76095","volume":"25","author":"A Follenzi","year":"2000","unstructured":"Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L . Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 2000; 25: 217\u2013222.","journal-title":"Nat Genet"},{"key":"BFgt201494_CR18","doi-asserted-by":"publisher","first-page":"e51952","DOI":"10.1371\/journal.pone.0051952","volume":"7","author":"V Pichard","year":"2012","unstructured":"Pichard V, Aubert D, Boni S, Battaglia S, Ivacik D, Nguyen TH et al. Specific micro RNA-regulated TetR-KRAB transcriptional control of transgene expression in viral vector-transduced cells. PLoS One 2012; 7: e51952.","journal-title":"PLoS One"},{"key":"BFgt201494_CR19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1182\/blood.V100.3.813","volume":"100","author":"T VandenDriessche","year":"2002","unstructured":"VandenDriessche T, Thorrez L, Naldini L, Follenzi A, Moons L, Berneman Z et al. Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 2002; 100: 813\u2013822.","journal-title":"Blood"},{"key":"BFgt201494_CR20","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1093\/nar\/19.15.4139","volume":"19","author":"RH Costa","year":"1991","unstructured":"Costa RH, Grayson DR . Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region. Nucleic Acids Res 1991; 19: 4139\u20134145.","journal-title":"Nucleic Acids Res"},{"key":"BFgt201494_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/mt.2008.231","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau RL, Martins I, Davidson BL . Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. Mol Ther 2009; 17: 169\u2013175.","journal-title":"Mol Ther"},{"key":"BFgt201494_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2613.2001.iep178.x","volume":"82","author":"P Arbuthnot","year":"2001","unstructured":"Arbuthnot P, Kew M . Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol 2001; 82: 77\u2013100.","journal-title":"Int J Exp Pathol"},{"key":"BFgt201494_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.patbio.2010.05.001","volume":"58","author":"C Brechot","year":"2010","unstructured":"Brechot C, Kremsdorf D, Soussan P, Pineau P, Dejean A, Paterlini-Brechot P et al. Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms. Pathol Biol (Paris) 2010; 58: 278\u2013287.","journal-title":"Pathol Biol (Paris)"},{"key":"BFgt201494_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1152\/physiolgenomics.00048.2004","volume":"18","author":"P Sinnayah","year":"2004","unstructured":"Sinnayah P, Lindley TE, Staber PD, Davidson BL, Cassell MD, Davisson RL . Targeted viral delivery of Cre recombinase induces conditional gene deletion in cardiovascular circuits of the mouse brain. Physiol Genom 2004; 18: 25\u201332.","journal-title":"Physiol Genom"},{"key":"BFgt201494_CR25","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1261\/rna.1887910","volume":"16","author":"YP Liu","year":"2010","unstructured":"Liu YP, Vink MA, Westerink JT, Ramirez de Arellano E, Konstantinova P, Ter Brake O et al. Titers of lentiviral vectors encoding shRNAs and miRNAs are reduced by different mechanisms that require distinct repair strategies. RNA 2010; 16: 1328\u20131339.","journal-title":"RNA"},{"key":"BFgt201494_CR26","first-page":"802","volume":"3","author":"ZS Guo","year":"1996","unstructured":"Guo ZS, Wang LH, Eisensmith RC, Woo SL . Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Therapy 1996; 3: 802\u2013810.","journal-title":"Gene Therapy"},{"key":"BFgt201494_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2009.04.010","volume":"286","author":"K Koike","year":"2009","unstructured":"Koike K . Hepatitis B virus X gene is implicated in liver carcinogenesis. Cancer Lett 2009; 286: 60\u201368.","journal-title":"Cancer Lett"},{"key":"BFgt201494_CR28","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1128\/jvi.68.3.2026-2030.1994","volume":"68","author":"F Zoulim","year":"1994","unstructured":"Zoulim F, Saputelli J, Seeger C . Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 1994; 68: 2026\u20132030.","journal-title":"J Virol"},{"issue":"Part 1","key":"BFgt201494_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0092-8674(81)90034-9","volume":"26","author":"K Shimotohno","year":"1981","unstructured":"Shimotohno K, Temin HM . Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus. Cell 1981; 26 (Part 1): 67\u201377.","journal-title":"Cell"},{"key":"BFgt201494_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jbiotec.2013.11.004","volume":"169","author":"L Osorio","year":"2014","unstructured":"Osorio L, Gijsbers R, Oliveras-Salva M, Michiels A, Debyser Z, Van den Haute C et al. Viral vectors expressing a single microRNA-based short-hairpin RNA result in potent gene silencing in vitro and in vivo. J Biotechnol 2014; 169: 71\u201381.","journal-title":"J Biotechnol"},{"key":"BFgt201494_CR31","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/mt.2009.48","volume":"17","author":"M Amendola","year":"2009","unstructured":"Amendola M, Passerini L, Pucci F, Gentner B, Bacchetta R, Naldini L . Regulated and multiple miRNA and siRNA delivery into primary cells by a lentiviral platform. Mol Ther 2009; 17: 1039\u20131052.","journal-title":"Mol Ther"},{"key":"BFgt201494_CR32","doi-asserted-by":"publisher","first-page":"11273","DOI":"10.1128\/JVI.76.22.11273-11282.2002","volume":"76","author":"J Zhuang","year":"2002","unstructured":"Zhuang J, Jetzt AE, Sun G, Yu H, Klarmann G, Ron Y et al. Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J Virol 2002; 76: 11273\u201311282.","journal-title":"J Virol"},{"key":"BFgt201494_CR33","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nmeth1079","volume":"4","author":"MS Ebert","year":"2007","unstructured":"Ebert MS, Neilson JR, Sharp PA . MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007; 4: 721\u2013726.","journal-title":"Nat Methods"},{"key":"BFgt201494_CR34","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","volume":"84","author":"MA Sells","year":"1987","unstructured":"Sells MA, Chen ML, Acs G . Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 1987; 84: 1005\u20131009.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201494_CR35","first-page":"e186","volume":"3","author":"S-R Lin","year":"2014","unstructured":"Lin S-R, Yang H-C, Kuo Y-T, Liu C-J, Yang T-Y, Sung K-C et al. The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo. Mol Ther 2014; 3: e186.","journal-title":"Mol Ther"},{"key":"BFgt201494_CR36","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1182\/blood-2003-09-3217","volume":"103","author":"A Follenzi","year":"2004","unstructured":"Follenzi A, Battaglia M, Lombardo A, Annoni A, Roncarolo MG, Naldini L . Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 2004; 103: 3700\u20133709.","journal-title":"Blood"},{"key":"BFgt201494_CR37","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ymthe.2005.06.482","volume":"12","author":"TH Nguyen","year":"2005","unstructured":"Nguyen TH, Bellodi-Privato M, Aubert D, Pichard V, Myara A, Trono D et al. Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats. Mol Ther 2005; 12: 852\u2013859.","journal-title":"Mol Ther"},{"key":"BFgt201494_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1089\/hgtb.2011.010","volume":"23","author":"V Pichard","year":"2012","unstructured":"Pichard V, Boni S, Baron W, Nguyen TH, Ferry N . Priming of hepatocytes enhances in vivo liver transduction with lentiviral vectors in adult mice. Hum Gene Ther Methods 2012; 23: 8\u201317.","journal-title":"Hum Gene Ther Methods"},{"key":"BFgt201494_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nmeth.2331","volume":"10","author":"M Ranzani","year":"2013","unstructured":"Ranzani M, Cesana D, Bartholomae CC, Sanvito F, Pala M, Benedicenti F et al. Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer. Nat Methods 2013; 10: 155\u2013161.","journal-title":"Nat Methods"},{"key":"BFgt201494_CR40","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S1525-0016(03)00169-2","volume":"8","author":"F Park","year":"2003","unstructured":"Park F, Ohashi K, Kay MA . The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo. Mol Ther 2003; 8: 314\u2013323.","journal-title":"Mol Ther"},{"key":"BFgt201494_CR41","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1182\/blood-2010-05-282707","volume":"117","author":"NJ Ward","year":"2011","unstructured":"Ward NJ, Buckley SM, Waddington SN, Vandendriessche T, Chuah MK, Nathwani AC et al. Codon optimization of human factor VIII cDNAs leads to high-level expression. Blood 2011; 117: 798\u2013807.","journal-title":"Blood"},{"key":"BFgt201494_CR42","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/mt.2009.143","volume":"17","author":"O Menzel","year":"2009","unstructured":"Menzel O, Birraux J, Wildhaber BE, Jond C, Lasne F, Habre W et al. Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates. Mol Ther 2009; 17: 1754\u20131760.","journal-title":"Mol Ther"},{"key":"BFgt201494_CR43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/B978-044450986-4\/50069-2","volume-title":"Frontiers in Viral Hepatitis","author":"PL Marion","year":"2003","unstructured":"Marion PL, Salazar FH, Liittschwager K, Bordier BB, Seeger C, Winters MA et al. Chapter 18\u2014a transgenic mouse lineage useful for testing antivirals targeting hepatitis B virus. In: Raymond FS, Jean-Pierre S, Charles M, RiceA2 - Raymond F, Schinazi J-PS, Charles MR (eds). Frontiers in Viral Hepatitis. Elsevier: Amsterdam, Netherlands, 2003, pp 197\u2013210."},{"key":"BFgt201494_CR44","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1128\/jvi.69.10.6158-6169.1995","volume":"69","author":"LG Guidotti","year":"1995","unstructured":"Guidotti LG, Matzke B, Schaller H, Chisari FV . High-level hepatitis B virus replication in transgenic mice. J Virol 1995; 69: 6158\u20136169.","journal-title":"J Virol"},{"key":"BFgt201494_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"BFgt201494_CR46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2893.2012.01602.x","volume":"19","author":"S Pol","year":"2012","unstructured":"Pol S, Lampertico P . First-line treatment of chronic hepatitis B with entecavir or tenofovir in 'real-life' settings: from clinical trials to clinical practice. J Viral Hepat 2012; 19: 377\u2013386.","journal-title":"J Viral Hepat"},{"key":"BFgt201494_CR47","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF01703079","volume":"8","author":"CT Bock","year":"1994","unstructured":"Bock CT, Schranz P, Schroder CH, Zentgraf H . Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes 1994; 8: 215\u2013229.","journal-title":"Virus Genes"},{"key":"BFgt201494_CR48","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1073\/pnas.79.13.3997","volume":"79","author":"WS Mason","year":"1982","unstructured":"Mason WS, Aldrich C, Summers J, Taylor JM . Asymmetric replication of duck hepatitis B virus DNA in liver cells: free minus-strand DNA. Proc Natl Acad Sci USA 1982; 79: 3997\u20134001.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201494_CR49","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1038\/mt.2013.170","volume":"21","author":"K Bloom","year":"2013","unstructured":"Bloom K, Ely A, Mussolino C, Cathomen T, Arbuthnot P . Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases. Mol Ther 2013; 21: 1889\u20131897.","journal-title":"Mol Ther"},{"key":"BFgt201494_CR50","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1517\/17425247.2010.533655","volume":"7","author":"MB Mowa","year":"2010","unstructured":"Mowa MB, Crowther C, Arbuthnot P . Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators. Expert Opin Drug Deliv 2010; 7: 1373\u20131385.","journal-title":"Expert Opin Drug Deliv"},{"key":"BFgt201494_CR51","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.1128\/JVI.78.11.5966-5972.2004","volume":"78","author":"DA Muruve","year":"2004","unstructured":"Muruve DA, Cotter MJ, Zaiss AK, White LR, Liu Q, Chan T et al. Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo. J Virol 2004; 78: 5966\u20135972.","journal-title":"J Virol"},{"key":"BFgt201494_CR52","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1073\/pnas.0500930102","volume":"102","author":"G Toietta","year":"2005","unstructured":"Toietta G, Mane VP, Norona WS, Finegold MJ, Ng P, McDonagh AF et al. Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci USA 2005; 102: 3930\u20133935.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201494_CR53","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrg2988","volume":"12","author":"F Mingozzi","year":"2011","unstructured":"Mingozzi F, High KA . Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet 2011; 12: 341\u2013355.","journal-title":"Nat Rev Genet"},{"key":"BFgt201494_CR54","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nm1549","volume":"13","author":"F Mingozzi","year":"2007","unstructured":"Mingozzi F, Maus MV, Hui DJ, Sabatino DE, Murphy SL, Rasko JE et al. CD8(+) T-cell responses to adeno-associated virus capsid in humans. Nat Med 2007; 13: 419\u2013422.","journal-title":"Nat Med"},{"key":"BFgt201494_CR55","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/jgm.1207","volume":"10","author":"C Rauschhuber","year":"2008","unstructured":"Rauschhuber C, Xu H, Salazar FH, Marion PL, Ehrhardt A . Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice. J Gene Med 2008; 10: 878\u2013889.","journal-title":"J Gene Med"},{"key":"BFgt201494_CR56","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1089\/hum.2012.229","volume":"24","author":"A Schambach","year":"2013","unstructured":"Schambach A, Zychlinski D, Ehrnstroem B, Baum C . Biosafety features of lentiviral vectors. Hum Gene Ther 2013; 24: 132\u2013142.","journal-title":"Hum Gene Ther"},{"key":"BFgt201494_CR57","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","volume":"72","author":"R Zufferey","year":"1998","unstructured":"Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 72: 9873\u20139880.","journal-title":"J Virol"},{"key":"BFgt201494_CR58","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2174\/156652308786848003","volume":"8","author":"C Frecha","year":"2008","unstructured":"Frecha C, Szecsi J, Cosset FL, Verhoeyen E . Strategies for targeting lentiviral vectors. Curr Gene Ther 2008; 8: 449\u2013460.","journal-title":"Curr Gene Ther"},{"key":"BFgt201494_CR59","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/TP.0b013e3181c28118","volume":"89","author":"J Birraux","year":"2010","unstructured":"Birraux J, Wildhaber BE, Jond C, Belli DC, Menzel O . Ex vivo hepatocyte gene therapy: increased biosafety protocol for transduction in suspension with lentiviral vectors and immediate transplantation (SLIT). Transplantation 2010; 89: 127\u2013129.","journal-title":"Transplantation"},{"key":"BFgt201494_CR60","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nature13020","volume":"508","author":"S Zhu","year":"2014","unstructured":"Zhu S, Rezvani M, Harbell J, Mattis AN, Wolfe AR, Benet LZ et al. Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature 2014; 508: 93\u201397.","journal-title":"Nature"},{"key":"BFgt201494_CR61","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ymthe.2005.07.358","volume":"12","author":"M Themis","year":"2005","unstructured":"Themis M, Waddington SN, Schmidt M, von Kalle C, Wang Y, Al-Allaf F et al. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol Ther 2005; 12: 763\u2013771.","journal-title":"Mol Ther"},{"key":"BFgt201494_CR62","doi-asserted-by":"publisher","first-page":"8957","DOI":"10.1128\/JVI.77.16.8957-8951.2003","volume":"77","author":"M Wiznerowicz","year":"2003","unstructured":"Wiznerowicz M, Trono D . Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003; 77: 8957\u20138961.","journal-title":"J Virol"},{"key":"BFgt201494_CR63","first-page":"3858","volume":"42","author":"H Nakabayashi","year":"1982","unstructured":"Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J . Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 1982; 42: 3858\u20133863.","journal-title":"Cancer Res"},{"key":"BFgt201494_CR64","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1182\/blood-2001-12-0249","volume":"101","author":"F Bovia","year":"2003","unstructured":"Bovia F, Salmon P, Matthes T, Kvell K, Nguyen TH, Werner-Favre C et al. Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors. Blood 2003; 101: 1727\u20131733.","journal-title":"Blood"},{"key":"BFgt201494_CR65","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/01.tp.0000234675.56598.35","volume":"82","author":"TH Nguyen","year":"2006","unstructured":"Nguyen TH, Birraux J, Wildhaber B, Myara A, Trivin F, Le Coultre C et al. Ex vivo lentivirus transduction and immediate transplantation of uncultured hepatocytes for treating hyperbilirubinemic Gunn rat. Transplantation 2006; 82: 794\u2013803.","journal-title":"Transplantation"},{"key":"BFgt201494_CR66","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1128\/jvi.66.7.4107-4116.1992","volume":"66","author":"M Nassal","year":"1992","unstructured":"Nassal M . The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 1992; 66: 4107\u20134116.","journal-title":"J Virol"},{"key":"BFgt201494_CR67","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/sj.mt.6300077","volume":"15","author":"MS Weinberg","year":"2007","unstructured":"Weinberg MS, Ely A, Barichievy S, Crowther C, Mufamadi S, Carmona S et al. Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA. Mol Ther 2007; 15: 534\u2013541.","journal-title":"Mol Ther"},{"key":"BFgt201494_CR68","first-page":"328","volume":"49","author":"MS Sands","year":"1999","unstructured":"Sands MS, Barker JE . Percutaneous intravenous injection in neonatal mice. Lab Anim Sci 1999; 49: 328\u2013330.","journal-title":"Lab Anim Sci"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201494.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201494","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201494.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:11:22Z","timestamp":1648555882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,23]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFgt201494"],"URL":"https:\/\/doi.org\/10.1038\/gt.2014.94","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,23]]},"assertion":[{"value":"17 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}